Robert Silbergleit
Physician · University of Michigan Health-Ann Arbor
Credentials: · ·
History
- 2019–Present
1992–1995
Research
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
New England Journal of Medicine · 2016 · 801 citations
Intramuscular versus intravenous therapy for prehospital status epilepticus
New England Journal of Medicine · 2012 · First of 8 authors · Corresponding · 477 citations
Very early administration of progesterone for acute traumatic brain injury
New England Journal of Medicine · 2014 · 455 citations
29 papers
- WM
25 papers
17 papers
17 papers
15 papers
15 papers
14 papers
14 papers
Grants
- 2025–2030
Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)
National Institute of Neurological Disorders and Stroke · UH3
PI · $5.7M · University of Virginia
- 2018–2029
Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $4.1M · University of Michigan at Ann Arbor
- 2017–2028
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $6.4M · University of Michigan at Ann Arbor
- 2019–2026
1/2 ICECAP: Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
National Heart, Lung, and Blood Institute · UH3
PI · $21.4M · University of Michigan at Ann Arbor
Clinical trials
- 2021–2022
Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
Principal investigator · Completed · Phase 1
Robert Silbergleit
- 2020–2021
Convalescent Plasma in Outpatients With COVID-19
Principal investigator · Completed · Phase 3
Stanford University
- 2020–2026
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
Principal investigator · Completed
University of Michigan
- 2015–2019
Established Status Epilepticus Treatment Trial
Principal investigator · Completed · Phase 3
University of Virginia